Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Nov 10, 2014)
  • 8-K (Nov 4, 2014)
  • 8-K (Aug 7, 2014)
  • 8-K (Jun 19, 2014)
  • 8-K (Jun 10, 2014)
  • 8-K (May 6, 2014)

 
Other

Genomic Health 8-K 2011

Documents found in this filing:

  1. 8-K
  2. Ex-99.1
  3. Graphic
  4. Graphic

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  November 1, 2011

 

GENOMIC HEALTH, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or Other Jurisdiction of
Incorporation)

 

000-51541

(Commission File Number)

 

77-0552594

(I.R.S. Employer
Identification No.)

 

301 Penobscot Drive

 

 

Redwood City, California

 

94063

(Address of principal executive offices)

 

(Zip Code)

 

(650) 556-9300

(Registrant’s telephone number,

including area code)

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

 

 

 



 

Item 2.02 Results of Operations and Financial Condition.

 

On November 1, 2011, Genomic Health, Inc. issued a press release announcing financial results for its third fiscal quarter ended September 30, 2011. The full text of the press release is furnished as Exhibit 99.1.

 

2



 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1  Press release issued by Genomic Health, Inc. dated November 1, 2011.

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 1, 2011

 

 

 

 

 

 

GENOMIC HEALTH, INC.

 

 

 

 

 

By:

/s/ Dean L. Schorno

 

 

Dean L. Schorno

 

 

Chief Financial Officer

 

4



 

GENOMIC HEALTH, INC.

EXHIBIT INDEX

 

Exhibit
Number

 

Description

99.1

 

Press release issued by Genomic Health, Inc. dated November 1, 2011

 

5


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki